Stem Cell Therapy Market 2017 Trends, Growth and Forecast to 2021
ReportsWeb.com published “Stem Cell Therapy Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, July 27, 2017 ) Stem cell therapy is the use of stem cells for the treatment or prevention of a disease or condition. Bone marrow transplant is the widely-used stem cell therapy, followed by therapies derived from umbilical cord blood. Research is being undertaken to develop various sources (such as cord blood cells, bone marrow, and skin) for stem cells, and to apply them to various disorders like neurodegenerative diseases and conditions such as heart disease, diabetes, and other conditions.
Publisher's analysts forecast the global stem cell therapy market to grow at a CAGR of 36.52% during the period 2017-2021.
For more information about this report: http://www.reportsweb.com/global-stem-cell-therapy-market-2017-2021 .
Covered in this report
The report covers the present scenario and the growth prospects of the global stem cell therapy market for 2017-2021. To calculate the market size, the report considers the sales of stem cell therapy products/segments in the market.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
Publisher's report, Global Stem Cell Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- Holostem Advanced Therapies
- JCR Pharmaceuticals
- Organogenesis
- Osiris Therapeutics
- Vericel
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001608751/sample .
Other prominent vendors
- AbbVie
- American CryoStem
- AM-Pharma
- Anterogen
- apceth Biopharma
- Astellas Pharma
- Athersys
- Baxter International
- Beike Biotechnology
- BIOTIME
- bluebird bio
- Bristol-Myers Squibb
- BrainStorm Cell Therapeutics
- Brainxell
- Caladrius Biosciences
- Cellular Biomedicine Group
- Cellular Dynamics International (a subsidiary of Fujifilm)
- Cesca Therapeutics
- CHA Biotech
- Chugai Pharmaceutical
- Citospin
- Corestem
- Cytori Therapeutics
- Daiichi Sankyo
- Fujifilm
- Gamida Cell
- Global Stem Cells Group
- Grupo Ferrer Internacional
- GlaxoSmithKline
- Hemostemix
- Histocell
- International Stem Cell
- Ivy Institute of Stem Cells
- Japan Regenerative Medicine
- Kangstem Biotech
- Kiadis Pharma
- Laboratorios Salvat
- MEDIPOST
- Mesoblast
- Nuo Therapeutics
- Opsis Therapeutics
- Osiris Therapeutics
- Pharmicell
- Pluristem Therapeutics
- Promethera Biosciences
- Q Therapeutics
- ReNeuron
- RHEACELL
- Salus Medical Solutions
- Sangamo Therapeutics
- Shire
- Steminent Biotherapeutics
- Sumitomo Dainippon Pharma
- Taiwan Bio Therapeutics
- Takeda Pharmaceutical
- Teva Pharmaceutical Industries
- Thoratec Corporation
- TiGenix
- Translational Biosciences
- TWO CELLS
- U.S. Stem Cell
- ViaCyte
- VistaGen Therapeutics
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001608751/buying .
Publisher's analysts forecast the global stem cell therapy market to grow at a CAGR of 36.52% during the period 2017-2021.
For more information about this report: http://www.reportsweb.com/global-stem-cell-therapy-market-2017-2021 .
Covered in this report
The report covers the present scenario and the growth prospects of the global stem cell therapy market for 2017-2021. To calculate the market size, the report considers the sales of stem cell therapy products/segments in the market.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
Publisher's report, Global Stem Cell Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- Holostem Advanced Therapies
- JCR Pharmaceuticals
- Organogenesis
- Osiris Therapeutics
- Vericel
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001608751/sample .
Other prominent vendors
- AbbVie
- American CryoStem
- AM-Pharma
- Anterogen
- apceth Biopharma
- Astellas Pharma
- Athersys
- Baxter International
- Beike Biotechnology
- BIOTIME
- bluebird bio
- Bristol-Myers Squibb
- BrainStorm Cell Therapeutics
- Brainxell
- Caladrius Biosciences
- Cellular Biomedicine Group
- Cellular Dynamics International (a subsidiary of Fujifilm)
- Cesca Therapeutics
- CHA Biotech
- Chugai Pharmaceutical
- Citospin
- Corestem
- Cytori Therapeutics
- Daiichi Sankyo
- Fujifilm
- Gamida Cell
- Global Stem Cells Group
- Grupo Ferrer Internacional
- GlaxoSmithKline
- Hemostemix
- Histocell
- International Stem Cell
- Ivy Institute of Stem Cells
- Japan Regenerative Medicine
- Kangstem Biotech
- Kiadis Pharma
- Laboratorios Salvat
- MEDIPOST
- Mesoblast
- Nuo Therapeutics
- Opsis Therapeutics
- Osiris Therapeutics
- Pharmicell
- Pluristem Therapeutics
- Promethera Biosciences
- Q Therapeutics
- ReNeuron
- RHEACELL
- Salus Medical Solutions
- Sangamo Therapeutics
- Shire
- Steminent Biotherapeutics
- Sumitomo Dainippon Pharma
- Taiwan Bio Therapeutics
- Takeda Pharmaceutical
- Teva Pharmaceutical Industries
- Thoratec Corporation
- TiGenix
- Translational Biosciences
- TWO CELLS
- U.S. Stem Cell
- ViaCyte
- VistaGen Therapeutics
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001608751/buying .
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results